Salarius Pharmaceuticals, Inc. Quarterly Common Stock, Shares, Issued from Q4 2014 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Salarius Pharmaceuticals, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q4 2014 to Q3 2024.
  • Salarius Pharmaceuticals, Inc. Common Stock, Shares, Issued for the quarter ending September 30, 2024 was 1.44M shares, a 63.4% decline year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 1.44M -2.5M -63.4% Sep 30, 2024 10-Q 2024-11-14
Q2 2024 641K -2.71M -80.9% Jun 30, 2024 10-Q 2024-08-09
Q1 2024 4.31M +1.85M +74.8% Mar 31, 2024 10-Q 2024-05-13
Q4 2023 492K -1.76M -78.2% Dec 31, 2023 10-Q 2024-11-14
Q3 2023 3.94M +1.69M +75.1% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 3.35M -52.8M -94% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 2.47M -44.2M -94.7% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 2.26M +446K +24.7% Dec 31, 2022 10-K 2024-03-22
Q3 2022 2.25M -42.9M -95% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 56.1M +11.3M +25.3% Jun 30, 2022 10-Q 2022-08-05
Q1 2022 46.7M +1.96M +4.39% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 1.81M -22M -92.4% Dec 31, 2021 10-K 2023-03-27
Q3 2021 45.2M +25.4M +128% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 44.8M +30.1M +206% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 44.7M +31.1M +228% Mar 31, 2021 10-Q 2021-05-12
Q4 2020 23.8M +19.3M +427% Dec 31, 2020 10-K 2022-03-25
Q3 2020 19.8M +16.1M +426% Sep 30, 2020 10-Q 2020-11-12
Q2 2020 14.6M -3.43M -19% Jun 30, 2020 10-Q 2020-08-12
Q1 2020 13.7M -4.42M -24.5% Mar 31, 2020 10-Q/A 2020-05-15
Q4 2019 4.52M +2.18M +93.2% Dec 31, 2019 10-K 2021-03-18
Q3 2019 3.77M -14.3M -79.1% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 18.1M 0 0% Jun 30, 2019 10-Q 2019-07-17
Q1 2019 18.1M +84.7K +0.47% Mar 31, 2019 10-Q 2019-05-01
Q4 2018 2.34M -15.6M -87% Dec 31, 2018 10-K 2020-03-23
Q3 2018 18.1M +97.7K +0.54% Sep 30, 2018 10-Q 2018-11-05
Q2 2018 18.1M +97.7K +0.54% Jun 30, 2018 10-Q 2018-08-01
Q1 2018 18M +14.2K +0.08% Mar 31, 2018 10-Q 2018-05-02
Q4 2017 18M +1.58K +0.01% Dec 31, 2017 10-K 2019-03-06
Q3 2017 18M +1.23K +0.01% Sep 30, 2017 10-Q 2017-11-06
Q2 2017 18M +3.34K +0.02% Jun 30, 2017 10-Q 2017-08-02
Q1 2017 18M +2.7K +0.02% Mar 31, 2017 10-Q 2017-05-03
Q4 2016 18M +26.7K +0.15% Dec 31, 2016 10-K 2018-03-07
Q3 2016 18M +27.9K +0.16% Sep 30, 2016 10-Q 2016-11-02
Q2 2016 18M +30.1K +0.17% Jun 30, 2016 10-Q 2016-08-03
Q1 2016 18M +34.2K +0.19% Mar 31, 2016 10-Q 2016-05-04
Q4 2015 17.9M +12.5M +230% Dec 31, 2015 10-K 2017-03-08
Q3 2015 17.9M Sep 30, 2015 10-Q 2015-11-04
Q2 2015 17.9M Jun 30, 2015 10-Q 2015-08-05
Q1 2015 17.9M Mar 31, 2015 10-Q 2015-05-06
Q4 2014 5.43M Dec 31, 2014 10-K 2016-03-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.